September 9, 2010 (FinancialWire) (Investrend Information Syndicate) (Go to http://www.financialwire.net/?s=ftrdnwswnd for all of today’s featured news.) — LightPath Technologies, Inc. (LPTH) a manufacturer, distributor and integrator of patented optical components and assemblies, yesterday announced two key management appointments. Brian Soller, Ph.D., a former Luna Innovations (LUNA) executive, has joined the company in the newly created position of vice president of corporate development and sales, and Alan Symmons, former director of engineering of LightPath, has been promoted to vice president of corporate engineering.

Jim Gaynor, CEO of LightPath Technologies, said, “The addition of Brian and Alan rounds out an already strong management team, and further supports our expansion efforts into new optics markets, including infrared products and value-added assemblies. Our new lenses, introduced in June, are designed for lasers used in the emerging biomedical instrumentation and data storage markets. Brian and Alan add the in-depth technical knowledge, industry experience and leadership skills to ensure the delivery of our new product lines, as well as our ongoing strategic growth initiatives, are a success.”

As vice president of corporate development and sales, Soller will be responsible for defining new market opportunities for the company's products, promoting LightPath’s technical capabilities and developing the LightPath brand. Soller will also be responsible for the management of LightPath's sales and marketing organization.

Mr. Soller comes to LightPath from Luna Innovations, a Nasdaq-traded company focused on sensing and instrumentation, and pharmaceutical nanomedicines for the healthcare, telecom, energy and defense industries. From 2001 to 2010, Soller held several senior management positions at Luna, including posts as vice president and general manager of Luna technologies division, division president of products division and corporate vice president of strategic business development. Soller holds a B.S. in physics and math from the University of Wisconsin and a Ph.D. in optical science from the University of Rochester. He is also a National Defense Science and Engineering Graduate Fellow.

Al Symmons has been part of LightPath's leadership team for the past four years. During that time, Symmons is credited with making significant corporate-wide improvements, including the organization and management of a technical staff; implementation of “LightFast”, a quick turnaround of product quotes and production of custom designs; and the development of new lens products that included low cost lenses, blue lenses and many custom designs. Symmons holds a B.S. in mechanical engineering from Rensselaer Polytechnic Institute, an MBA from the University of Arizona and has completed significant course work in optical sciences. Symmons will continue to report to CEO Jim Gaynor.

More about LPTH: Other FinancialWire(tm) news about LightPath is accessible via The FinancialWire(tm) search function (at http://www.financialwire.net/?s=lpthnas), additional information and independent research on LightPath is available via Investrend Syndications (at http://www.investrend.com/synd0003), and official information and company filings from LightPath are accessible via the SEC website (at http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001366669).

=========

Equity research on any public company is available through the Shareholders Research Alliance (go to http://www.investrend.com/synd0004 for more information).  Real-time, streaming research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://investrend.stocksmart.com/ss/html/hpcompany.html).  Current valuation analysis research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://www.valuengine.com/rep/searchsrep?pid=42&srchfor=).

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public other companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (at http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation from subject entities, companies, equities, or representatives thereof, for its news, opinions or distributions. Further disclosure is posted at the FinancialWire(tm) website (at http://www.financialwire.net/disclosures.php and http://www.financialwire.net/2010/04/23/safe-harbor/). Additional resources for investors are also accessible via the FinancialWire(tm) website (at http://www.financialwire.net/2010/04/23/investor-resources/). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Copyright © MMX, FinancialWire(tm); All rights reserved.

[ssryrsyr] [pltfrm] [lpthnas] [synd0003] [bsdarrgnmnt] [grdnstscrts] [ndstrls] [mnfctrng] [ndstrlspplssrvcs] [tchnlgy] [advnctchnlgy] [biomedphrm] [ftrdnwswnd] [clvloy] [bsnnssb] [restrctrng]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.